Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

235
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
235
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

279
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
279
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

211
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
211
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

219
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
219
Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Contemporary Treatment Responses of Recurrent Focal Segmental Glomerulosclerosis or Steroid Resistant Nephrotic Syndrome in Children after Kidney Transplantation: Phase 2 of a Multicenter Electronic Health Record Data Analysis.

Research square·2026
Same author

Comparative Effectiveness of Antihypertensive Medications in Children With Chronic Kidney Disease.

JAMA pediatrics·2026
Same author

Trends in US Children's Mortality, Chronic Conditions, Obesity, Functional Status, and Symptoms.

JAMA·2025
Same author

Clinical characteristics and favorable treatment responses of recurrent focal segmental glomerulosclerosis or steroid-resistant nephrotic syndrome in children after kidney transplantation.

Pediatric nephrology (Berlin, Germany)·2024
Same author

Retrospective Multicenter Cohort Study on Safety and Electroencephalographic Response to Lacosamide for Neonatal Seizures.

Pediatric neurology·2024
Same journal

Less Is More! An Analysis of Postoperative Outcomes Comparing Low-Dose E. Coli-Derived rhBMP-2 and Mammalian rhBMP-2 in Lateral Lumbar Spinal Fusion Surgery.

Clinical spine surgery·2026
Same journal

Preoperative Distal Motor Latency Testing and Long-Term Outcomes in Combined Lumbar Spinal Stenosis: A Retrospective Analysis of Diagnostic Discordance.

Clinical spine surgery·2026
Same journal

Differential Mechanisms of Ligamentum Flavum Hypertrophy: A Comparative MRI Analysis of Lumbar Spine Degeneration Patterns.

Clinical spine surgery·2026
Same journal

Discrepancy Between Global-Specific and Disease-Specific Outcome Measures Following Cervical Spine Surgery.

Clinical spine surgery·2026
Same journal

A Higher American Society of Anesthesiologists Classification Does Not Correlate With Inferior Outcomes Following Cervical Disk Replacement.

Clinical spine surgery·2026
Same journal

A Break-Even Cost Analysis for Venous Thromboembolism Prophylaxis in Posterior Lumbar Fusion Surgery.

Clinical spine surgery·2026
See all related articles

Related Experiment Video

Updated: Mar 13, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

The Minimally Important Clinical Difference.

Mitchell G Maltenfort1

  • 1Division of Orthopaedic Surgery, The Rothman Institute, Philadelphia, PA.

Clinical Spine Surgery
|October 19, 2016
PubMed
Summary
This summary is machine-generated.

The minimally important clinical difference (MCID) represents the smallest change in patient outcomes that matters. Understanding MCID is crucial for clinical studies and patient-centered surgical care.

More Related Videos

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.3K
Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD
09:47

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Published on: September 13, 2018

17.4K

Related Experiment Videos

Last Updated: Mar 13, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.3K
Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD
09:47

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Published on: September 13, 2018

17.4K

Area of Science:

  • Clinical outcomes research
  • Patient-reported outcome measures
  • Surgical innovation

Background:

  • The minimally important clinical difference (MCID) is the smallest measurable change in an outcome score that signifies a patient benefit.
  • MCID estimation commonly uses statistical detection thresholds or anchor-based methods comparing patient groups.
  • Defining MCID is essential for interpreting clinical trial results and ensuring patient-centeredness in healthcare.

Purpose of the Study:

  • To define the concept and significance of the minimally important clinical difference (MCID).
  • To highlight the role of MCID in patient-centered care and clinical research design.

Main Methods:

  • Literature review and conceptual synthesis of MCID definitions.
  • Analysis of MCID's application in clinical research and patient benefit assessment.

Main Results:

  • MCID is defined as the smallest change in outcome score meaningful to patients.
  • MCID can be estimated statistically or via anchor-based questions.
  • MCID is vital for determining clinically relevant treatment effects from the patient's perspective.

Conclusions:

  • The minimally important clinical difference (MCID) is a critical metric for evaluating treatment efficacy and patient benefit.
  • MCID informs the design of clinical trials, particularly in sample size calculations (power analyses).
  • Incorporating MCID ensures that research outcomes reflect genuine improvements in patient well-being.